￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Safety assessment and recommendations for long-term use of Lemborexant

2026-02-01 22:25:32

Check Details
Which company produces Lusutrombopag and analysis of drug sales channels

2026-02-01 22:25:32

Check Details
Omarigliptin usage, dosage and medication precautions explained

2026-02-01 22:25:32

Check Details
Detailed analysis of whether lecanemab-LEQEMBI is included in medical insurance and patient self-payment

2026-02-01 22:25:32

Check Details
Analysis of golodirsen side effects, adverse reactions and medication safety recommendations

2026-02-01 22:25:32

Check Details
An analysis of the clinical medication regimens and precautions for different patients with Vidicitomab (Aidexi)

2026-02-01 22:25:32

Check Details
Isatuximab is produced and developed by which company?

2026-02-01 22:25:32

Check Details
Whether capivasertib tablets (capivasertib) has been included in the medical insurance and reimbursement policy

2026-02-01 22:25:32

Check Details
The latest market price and reference cost of Guselkumab in 2026

2026-02-01 22:25:32

Check Details
Tenapanor reimbursement ratio and patient cost analysis

2026-02-01 22:25:32

Check Details
What is revumenib-REVUFORJ and analysis of its pharmacological effects

2026-02-01 22:25:32

Check Details
Why is Guanfacine not recommended to be taken casually and its possible risks

2026-02-01 22:25:32

Check Details
Category
相关知识